Description
Health Canada is offering an option for a rolling review of a new drug submission (NDS) or supplement to a new drug submission (SNDS) that meets specific eligibility conditions. Sponsors nearing the end of clinical development of a drug can apply to Health Canada for rolling review status for a forthcoming drug submission.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility | HTML | Open resource | |
| Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility | HTML | Open resource |